MSIF news | 16 January 2013
At an MSIF-supported meeting for people affected by MS or neuromyelitis optics (NMO) in China in 2012, we asked people what it is like to have MS/NMO and made it into a film.
MSIF news | 15 January 2013
MSIF is at an exciting stage of its development. We have big plans to change the global MS landscape over the next three years. Come and join us!
We are embarking on our first global fundraising growth strategy, and are looking for a passionate and driven fundraising expert to join us as Head of International Fundraising.
News from MS organisations | 13 January 2013
Ann Gonsalvez of MS Society India, Chennai was presented with the K. Venkatanarayana TANKER Foundation Awareness Award at an event held in Chennai on 25 January 2013.
MSIF news | 08 January 2013
The People with MS Advisory Committee (PMSAC) is a newly formed group who will advise the MSIF Board of Trustees on any issues related to the needs and aspirations of people with and affected by MS.
MSIF news | 01 January 2013
In 2012, MSIF launched a programme to update the Atlas of MS website, which currently contains epidemiological and resource accessibility data for 112 countries around the world.
News from MS organisations | 05 December 2012
Monday 2 December was the International Day for Persons with Disabilities – a day when people all over the world come together for a shared goal; to improve the lives of people with disabilities whatever their condition or nationality.
News from MS organisations | 03 December 2012
The conference, titled “Social Media – a new tool for the work of MS patient advocates and MS professionals”, took place from 24-25 November 2012, and was the first time RIMS and EMSP had collaborated on a conference together.
News from MS organisations | 18 November 2012
Since it was established in 2004, the Multiple Sclerosis Patients’ Friends Society of Palestine (MSPF) has been tirelessly campaigning to raise awareness of MS and improve access to treatment.
News from MS organisations | 14 November 2012
The US Food and Drug Administration has approved teriflunomide once-daily pills (brand name Aubagio) to treat people in the US with relapsing forms of MS.
MSIF news | 08 November 2012
MSIF representatives visited the Association Tunisienne des Malades de la Sclérose en Plaques in October 2012